Operating Lease, Right-of-Use Asset of UroGen Pharma Ltd. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
UroGen Pharma Ltd. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • UroGen Pharma Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,098,000, a 194% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

UroGen Pharma Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,098,000 +$2,046,000 +194% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,210,000 -$40,000 -3.2% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $641,000 -$802,000 -56% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $849,000 +$849,000 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $1,052,000 -$853,000 -45% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $1,250,000 -$857,000 -41% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,443,000 -$886,000 -38% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $0 -$2,452,000 -100% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 $1,905,000 -$761,000 -29% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $2,107,000 -$9,000 -0.42% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $2,329,000 +$1,384,000 +146% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,452,000 +$1,272,000 +108% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $2,666,000 +$1,248,000 +88% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $2,116,000 +$463,000 +28% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $945,000 -$235,000 -20% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $1,180,000 -$978,000 -45% 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 $1,418,000 -$1,234,000 -47% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $1,653,000 -$1,358,000 -45% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $1,180,000 -$2,253,000 -66% 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $2,158,000 -$1,577,000 -42% 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q3 2020 $2,652,000 +$229,000 +9.5% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $3,011,000 +$454,000 +18% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $3,433,000 +$656,000 +24% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $3,735,000 +$713,000 +24% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 $2,423,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $2,557,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $2,777,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $3,022,000 01 Jan 2019 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.